APO RESEARCH · REPORT
Custom Antibody Services
Custom antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.
Product & engineering
Understand the product.
Custom antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.
Selected research
Market Outlook & Growth Opportunities
Global Custom Antibody Services Market Outlook and Growth Opportunities 2026
Market perspective
Custom antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.
North America is the largest region of Custom Antibody Services, with a market share about 40%. It was followed by Europe with 30%. ThermoFisher, Bio-Rad and Covance are the top 3 players of industry, and they had more than 50% combined market share.
This report provides an overview of the global Custom Antibody Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Custom Antibody Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Custom Antibody Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Custom Antibody Services market.
Custom Antibody Services Segment by Company
ThermoFisher
GenScript
Abcam
MBS
ROCKLAND
ProSci
Biocompare
Bio-Rad
Covance
Capra Science
Innovagen
LIFE SCIENCE GROUP
Randox
GL Biochem
Abgent
Custom Antibody Services Segment by Type
Monoclonal
Polyclonal
Others
Custom Antibody Services Segment by Application
BioScience Companies
BioScience Research Institutions
Hospitals
Custom Antibody Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Custom Antibody Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Custom Antibody Services key companies, revenue, market share, and recent developments.
3. To split the Custom Antibody Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Custom Antibody Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Custom Antibody Services significant trends, drivers, influence factors in global and regions.
6. To analyze Custom Antibody Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Antibody Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom Antibody Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Antibody Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Custom Antibody Services industry.
Chapter 3: Detailed analysis of Custom Antibody Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Custom Antibody Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Custom Antibody Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Monoclonal
- Polyclonal
- Others
Applications
- BioScience Companies
- BioScience Research Institutions
- Hospitals
Companies covered
- ThermoFisher
- GenScript
- Abcam
- MBS
- ROCKLAND
- ProSci
- Biocompare
- Bio-Rad
- Covance
- Capra Science
- Innovagen
- LIFE SCIENCE GROUP
- Randox
- GL Biochem
- Abgent
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Custom Antibody Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Custom Antibody Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Custom Antibody Services Market Dynamics
- 2.1 Custom Antibody Services Industry Trends
- 2.2 Custom Antibody Services Industry Drivers
- 2.3 Custom Antibody Services Industry Opportunities and Challenges
- 2.4 Custom Antibody Services Industry Restraints
3 Custom Antibody Services Market by Company
- 3.1 Global Custom Antibody Services Company Revenue Ranking in 2025
- 3.2 Global Custom Antibody Services Revenue by Company (2021-2026)
- 3.3 Global Custom Antibody Services Company Ranking (2024-2026)
- 3.4 Global Custom Antibody Services Company Manufacturing Base and Headquarters
- 3.5 Global Custom Antibody Services Company Product Type and Application
- 3.6 Global Custom Antibody Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Custom Antibody Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Custom Antibody Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Custom Antibody Services Market by Type
- 4.1 Custom Antibody Services Type Introduction
- 4.1.1 Monoclonal
- 4.1.2 Polyclonal
- 4.1.3 Others
- 4.2 Global Custom Antibody Services Sales Value by Type
- 4.2.1 Global Custom Antibody Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Custom Antibody Services Sales Value by Type (2021-2032)
- 4.2.3 Global Custom Antibody Services Sales Value Share by Type (2021-2032)
5 Custom Antibody Services Market by Application
- 5.1 Custom Antibody Services Application Introduction
- 5.1.1 BioScience Companies
- 5.1.2 BioScience Research Institutions
- 5.1.3 Hospitals
- 5.2 Global Custom Antibody Services Sales Value by Application
- 5.2.1 Global Custom Antibody Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Custom Antibody Services Sales Value by Application (2021-2032)
- 5.2.3 Global Custom Antibody Services Sales Value Share by Application (2021-2032)
6 Custom Antibody Services Regional Value Analysis
- 6.1 Global Custom Antibody Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Custom Antibody Services Sales Value by Region (2021-2032)
- 6.2.1 Global Custom Antibody Services Sales Value by Region: 2021-2026
- 6.2.2 Global Custom Antibody Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Custom Antibody Services Sales Value (2021-2032)
- 6.3.2 North America Custom Antibody Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Custom Antibody Services Sales Value (2021-2032)
- 6.4.2 Europe Custom Antibody Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Custom Antibody Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Custom Antibody Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Custom Antibody Services Sales Value (2021-2032)
- 6.6.2 South America Custom Antibody Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Custom Antibody Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Custom Antibody Services Sales Value Share by Country, 2025 VS 2032
7 Custom Antibody Services Country-level Value Analysis
- 7.1 Global Custom Antibody Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Custom Antibody Services Sales Value by Country (2021-2032)
- 7.2.1 Global Custom Antibody Services Sales Value by Country (2021-2026)
- 7.2.2 Global Custom Antibody Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Custom Antibody Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Custom Antibody Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Custom Antibody Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 ThermoFisher
- 8.1.1 ThermoFisher Company Information
- 8.1.2 ThermoFisher Business Overview
- 8.1.3 ThermoFisher Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 8.1.4 ThermoFisher Custom Antibody Services Product Portfolio
- 8.1.5 ThermoFisher Recent Developments
- 8.2 GenScript
- 8.2.1 GenScript Company Information
- 8.2.2 GenScript Business Overview
- 8.2.3 GenScript Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 8.2.4 GenScript Custom Antibody Services Product Portfolio
- 8.2.5 GenScript Recent Developments
- 8.3 Abcam
- 8.3.1 Abcam Company Information
- 8.3.2 Abcam Business Overview
- 8.3.3 Abcam Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 8.3.4 Abcam Custom Antibody Services Product Portfolio
- 8.3.5 Abcam Recent Developments
- 8.4 MBS
- 8.4.1 MBS Company Information
- 8.4.2 MBS Business Overview
- 8.4.3 MBS Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 8.4.4 MBS Custom Antibody Services Product Portfolio
- 8.4.5 MBS Recent Developments
- 8.5 ROCKLAND
- 8.5.1 ROCKLAND Company Information
- 8.5.2 ROCKLAND Business Overview
- 8.5.3 ROCKLAND Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 8.5.4 ROCKLAND Custom Antibody Services Product Portfolio
- 8.5.5 ROCKLAND Recent Developments
- 8.6 ProSci
- 8.6.1 ProSci Company Information
- 8.6.2 ProSci Business Overview
- 8.6.3 ProSci Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 8.6.4 ProSci Custom Antibody Services Product Portfolio
- 8.6.5 ProSci Recent Developments
- 8.7 Biocompare
- 8.7.1 Biocompare Company Information
- 8.7.2 Biocompare Business Overview
- 8.7.3 Biocompare Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 8.7.4 Biocompare Custom Antibody Services Product Portfolio
- 8.7.5 Biocompare Recent Developments
- 8.8 Bio-Rad
- 8.8.1 Bio-Rad Company Information
- 8.8.2 Bio-Rad Business Overview
- 8.8.3 Bio-Rad Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 8.8.4 Bio-Rad Custom Antibody Services Product Portfolio
- 8.8.5 Bio-Rad Recent Developments
- 8.9 Covance
- 8.9.1 Covance Company Information
- 8.9.2 Covance Business Overview
- 8.9.3 Covance Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 8.9.4 Covance Custom Antibody Services Product Portfolio
- 8.9.5 Covance Recent Developments
- 8.10 Capra Science
- 8.10.1 Capra Science Company Information
- 8.10.2 Capra Science Business Overview
- 8.10.3 Capra Science Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 8.10.4 Capra Science Custom Antibody Services Product Portfolio
- 8.10.5 Capra Science Recent Developments
- 8.11 Innovagen
- 8.11.1 Innovagen Company Information
- 8.11.2 Innovagen Business Overview
- 8.11.3 Innovagen Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 8.11.4 Innovagen Custom Antibody Services Product Portfolio
- 8.11.5 Innovagen Recent Developments
- 8.12 LIFE SCIENCE GROUP
- 8.12.1 LIFE SCIENCE GROUP Company Information
- 8.12.2 LIFE SCIENCE GROUP Business Overview
- 8.12.3 LIFE SCIENCE GROUP Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 8.12.4 LIFE SCIENCE GROUP Custom Antibody Services Product Portfolio
- 8.12.5 LIFE SCIENCE GROUP Recent Developments
- 8.13 Randox
- 8.13.1 Randox Company Information
- 8.13.2 Randox Business Overview
- 8.13.3 Randox Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 8.13.4 Randox Custom Antibody Services Product Portfolio
- 8.13.5 Randox Recent Developments
- 8.14 GL Biochem
- 8.14.1 GL Biochem Company Information
- 8.14.2 GL Biochem Business Overview
- 8.14.3 GL Biochem Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 8.14.4 GL Biochem Custom Antibody Services Product Portfolio
- 8.14.5 GL Biochem Recent Developments
- 8.15 Abgent
- 8.15.1 Abgent Company Information
- 8.15.2 Abgent Business Overview
- 8.15.3 Abgent Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 8.15.4 Abgent Custom Antibody Services Product Portfolio
- 8.15.5 Abgent Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst